DPSCREEN: Dynamic personalized screening

Advances in Neural Information Processing Systems

Volumn 2017-December, Issue , 2017, Pages 1322-1333

  Ahuja, Kartik ^a   Zame, William R ^a   Van Der Schaar, Mihaela ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; RANDOM PROCESSES; STOCHASTIC SYSTEMS;

BREAST CANCER DATA; DISEASE DETECTION; DISEASE MODELS; DISEASE STATE; ELECTRONIC HEALTH RECORD; EXPECTED DELAY; EXTERNAL INFORMATIONS; OPTIMAL POLICIES;

DIAGNOSIS;

EID: 85046994322     PISSN: 10495258     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (50)

1. Siu, A. L. (2016). Screening for breast cancer: US Preventive Services Task Force recommendation statement. Annals of internal medicine, 164(4), pp.279-296.
2. Canto, M. et al. (2013). International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer, Gut, 62(3), pp.339-347.
3. Wilson, J. et al. (1968). Principles and practice of screening for disease.
4. Jemal, A. et al. (2010). Cancer statistics, CA: a cancer journal for clinicians, 60(5), pp.277-300.
5. Rulyak, S. J. et al. (2003). Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds, Gastrointestinal endoscopy, 57(1), pp.23-29.
6. Pace, L. E., & Keating, N. L. (2014). A systematic assessment of benefits and risks to guide breast cancer screening decisions. Jama, 311(13), 1327-1335.
7. Ayer, T. et al. (2012). OR forum-a POMDP approach to personalize mammography screening decisions. Operations Research, 60(5), pp.1019-1034.
8. Maillart, L. M. et al. (2008). Assessing dynamic breast cancer screening policies. Operations Research, 56(6), pp.1411-1427.
9. Erenay, F. S. et al. (2014). Optimizing colonoscopy screening for colorectal cancer prevention and surveillance, Manufacturing & Service Operations Management, 16(3), pp.381-400.
10. Rizopoulos, D. et al. (2015). Personalized screening intervals for biomarkers using joint models for longitudinal and survival data. Biostatistics, 17(1), pp.149-164.
11. Cox, D. R. (1992). Regression models and life-tables. In Breakthroughs in statistics. Springer New York.
12. Miller Jr, R. G. (2011). Survival analysis, John Wiley & Sons.
13. Crowder, M. J. (2001). Classical competing risks. CRC Press.
14. Lee, M. L. T. et al. (2003). First hitting time models for lifetime data, Handbook of statistics, 23, pp.537-543.
15. Cox, D. R. (1992). Regression models and life-tables. In Breakthroughs in statistics. Springer New York, pp. 527-541.
16. Si, X. S. et al. (2011). Remaining useful life estimation-A review on the statistical data driven approaches. European journal of operational research, 213(1), pp.1-14.
17. Lee, M. L. T. et al. (2006). Threshold regression for survival analysis: modeling event times by a stochastic process reaching a boundary. Statistical Science, pp.501-513.
18. Pineau, J. et al. (2003). Point-based value iteration: An anytime algorithm for POMDPs, n Joint Conference on Artificial Intelligence, 3, pp. 1025-1032.
19. Kim, D. et al. (2011). Point-based value iteration for constrained POMDPs, in Joint Conference on Artificial Intelligence, pp. 1968-1974.
20. Yu, H. (2006). Approximate solution methods for partially observable Markov and semi-Markov decision processes, Doctoral dissertation, Massachusetts Institute of Technology.
21. Krishnamurthy, V. (2016). Partially Observed Markov Decision Processes. Cambridge University Press.
22. Elson, S. L. et al. (2013). The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care. Breast cancer research and treatment, 140(2), pp.417-425.
23. Guiot, C. et al. (2003). Does tumor growth follow a "universal law"?, Journal of theoretical biology, 225(2), pp.147-151.
24. Gail, M. H. et al. (1989). Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. Journal of the National Cancer Institute, 81(24), 1879-1886.
25. Baxter, N. (2002). Breast self-examination, Canadian Medical Association Journal, Chicago, 166(2), pp.166-168.
26. Thomas, D. B. et al. (2002). Randomized trial of breast self-examination in Shanghai: final results. Journal of the National Cancer Institute, 94(19), 1445-1457.
27. Oeffinger, K. C. et al. (2015). Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. Jama, 314(15), 1599-1614.
28. Nelson, H. D. et al. (2009). Screening for breast cancer: an update for the US Preventive Services Task Force. Annals of internal medicine, 151(10), 727-737.
29. Klabunde, C. N. et al. (2007). Evaluating population-based screening mammography programs internationally. In Seminars in breast disease, International Breast Cancer Screening Network, 10(2), pp. 102-107.
30. Sener, S. F. et al. (1999). Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. Journal of the American College of Surgeons, 189(1), pp.1-7.
31. Armstrong, K. et al. (2007). Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Annals of internal medicine, 146(7), 516-526.
32. Liebman, M. N. (2007). Personalized medicine: a perspective on the patient, disease and causal diagnostics, 171-174.
33. Mandelblatt, J. S. et al. (1992). Breast cancer screening for elderly women with and without comorbid conditions. Ann Intern Med, 116, 722-730.
34. Alaa, A. M. et al. (2016). Balancing suspense and surprise: Timely decision making with endogenous information acquisition, in Advances in Neural Information Processing Systems (NIPS), pp. 2910-2918.
35. Schulam, P. et al. (2016). Disease Trajectory Maps, in Advances In Neural Information Processing Systems (NIPS), pp. 4709-4717.
36. Rizopoulos, D. (2011). Dynamic Predictions and Prospective Accuracy in Joint Models for Longitudinal and Time to Event Data. Biometrics, 67(3), 819-829.
37. Meira-Machado, L. et al. (2006). Nonparametric estimation of transition probabilities in a non-Markov illness-death model. Lifetime Data Analysis, 12(3), 325-344.
38. Krishnamurthy, V. (2017). POMDP Structural Results for Controlled Sensing. arXiv preprint arXiv:1701.00179.
39. Smallwood, R. D., & Sondik, E. J. (1973). The optimal control of partially observable Markov processes over a finite horizon. Operations research, 21(5), 1071-1088.
40. Verdinelli, I. et al. (1992). Bayesian designs for maximizing information and outcome, Journal of the American Statistical Association, 87(418), 510-515.
41. Daskivich, T. J. et al. (2011). Overtreatment of men with low-risk prostate cancer and significant comorbidity, Cancer, 117(10), 2058-2066.
42. Alagoz, O et al. (2011). Operations research models for cancer screening, Wiley Encyclopedia of Operations Research and Management Science.
43. Elmore, J. G. et al. (2005). Efficacy of breast cancer screening in the community according to risk level. Journal of the National Cancer Institute, 97(14), 1035-1043.
44. Vilaprinyo et al (2014). Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer, PloS one. 9(2), p.e86858.
45. Trentham-Dietz et al. (2016) Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes Risk-Based Breast Cancer Screening Intervals, Annals of Internal Medicine, 165(10), pp.700-712.
46. Loeve, F. et al (1999). The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Computers in Biomedical Research, 32(1), pp.13-33.
47. Zauber, A. G. et al. (2009) Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the US Preventive Services Task Force. Annals of Internal Medicine, 149(9), pp.659-669.
48. Frazier, A. L et al. (2000) Cost-effectiveness of screening for colorectal cancer in the general population, JAMA, 284(15), pp.1954-1961.
49. Whitlock et al. (2008) Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the US Preventive Services Task Force Screening for Colorectal Cancer. Annals of Internal Medicine, 149(9), pp.638-658.
50. Alaa, A.M. et al. (2016). ConfidentCare: A Clinical Decision Support System for Personalized Breast Cancer Screening, accepted and to appear in IEEE Transactions on Multimedia-Special Issue on Multimedia-based Healthcare, 18(10), pp.1942-1955.